Skip to main content
. 2019 Jun 3;19:72. doi: 10.1186/s12905-019-0770-x

Table 2.

Risk Factors in the Study Population, p-values from Chi-square test for Comparison between Cases and Controls

Factor Cases (n = 224)
N (%)
Controls (n = 225)
N (%)
p-value1
Age in years (N = 449)
 18–35 31 (13.84) 31 (13.78) 0.988
 36–45 89 (39.73) 91 (40.44)
 46–65 104 (46.43) 103 (45.78)
Breastfeeding (N = 450)
 Yes 144 (64) 154 (68.44) 0.522
 No 25 (11.11) 19 (8.44)
 N/A* 56 (24.89) 52 (23.11)
Duration of breastfeeding in years (N = 449)
  ≤ 1 50 (22.32) 61 (27.11) 0.610
  > 1 94 (41.96) 93 (41.33)
 No 24 (10.71) 19 (8.44)
 N/A* 56 (25) 52 (23.11)
Pregnancy (N = 450)
 Yes 115 (51.11) 173 (76.89) 0.000
 No 110 (48.890 52 (23.11)
Miscarriage (N = 450)
 Yes 92 (40.89) 84 (37.33) 0.249
 No 133 (59.11) 141 (62.67)
Menopausal Status (N = 450)
 Premenopausal 101 (44.89) 74 (32.89) 0.006
 Postmenopausal 124 (55.11) 151 (67.11)
Regularity of Period (N = 449)
 Yes 190 (84.82) 203 (90.22) 0.056
 No 34 (15.18) 22 (9.78)
Personal history of cancer (ovarian, rectal, etc.) (N = 449)
 Yes 27 (12.05) 0 (0) 0.000
 No 197 (87.95) 225 (100)
First or second – degree relative have cancer (N = 449)
 Yes 109 (48.66) 34 (15.11) 0.000
 No 115 (51.34) 191 (84.89)
Smoking Status (N = 448)
 Past Smoker 25 (11.21) 1 (0.44) 0.000
 Current Smoker 11 (4.93) 25 (11.11)
 Never Smoked 187 (83.86) 199 (88.44)
Hormonal Therapy for Menstrual Irregularities (N = 447)
 Yes 24 (10.81) 13 (5.78) 0.060
 No 198 (89.19) 212 (94.22)
Postmenopausal Hormonal Therapy (i = 448)
 Yes 8 (3.59) 0 (0) 0.004
 No 215 (96.41) 225 (100)
Regular Use of Oral Contraceptives (N = 446)
 Yes 87 (39.01) 48 (21.52) 0.000
 No 136 (60.99) 175 (78.48)
Oral Contraceptives Type (N = 81)
 COC* 31 (49.21) 10 (55.56) 0.063
 POC* 32 (50.79) 8 (44.44)

*N/A Not Applicable

*POC Progestin-Only Contraceptives

*COCs Combined Oral Contraceptives

1Chi-square test